sellModerate cluster of 3
Leslie D. Funtleyder sold $79k of APLT
Chief Financial Officer at Applied Therapeutics, Inc.. 13,530 shares at an average of $5.83, traded Aug 22, 2024, filed Aug 23, 2024.
Warning score
46Value
$79k
13,530 shares
Holdings after
277,911
-5% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +22RoleCFO
- +9Trade size$79k at market
- 0Share of holdings soldSold 4.6% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-100222, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 22, 2024 | SOpen-market sale Common Stock | -13,530 | $5.83 | $79k | 277,911 | Aug 23, 2024 |
Related signals
Other insiders at Applied Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | APLTsell Applied Therapeutics, Inc. | Stacy J. Kanter director | $4,816 43,000 shares | -40% | |
| 30Weak | Applied Therapeutics, Inc. | Constantine Chinoporos See Remarks | $197 447 shares | -0% | |
| 30Weak | Applied Therapeutics, Inc. | Leslie D. Funtleyder See Remarks | $6,381 14,502 shares | -4% | |
| 30Weak | Applied Therapeutics, Inc. | Riccardo Perfetti Chief Medical Officer | $4,561 10,366 shares | -1% | |
| 30Weak | Applied Therapeutics, Inc. | Constantine Chinoporos See Remarks | $17k 28,117 shares | -9% | |
| 37Weak | Applied Therapeutics, Inc. | Riccardo Perfetti Chief Medical Officer | $53k 86,078 shares | -9% | |
| 30Weak | Applied Therapeutics, Inc. | Leslie D. Funtleyder See Remarks | $14k 22,950 shares | -5% | |
| 41Moderate | Applied Therapeutics, Inc. | Riccardo Perfetti Chief Medical Officer | $132k 22,681 shares | -2% | |
| 70Notable | Applied Therapeutics, Inc. | Shoshana Shendelman President and CEO | $4.7M 777,014 shares | -14% | |
| 45Moderate | Applied Therapeutics, Inc. | Leslie D. Funtleyder Chief Financial Officer | $73k 16,980 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.